Lenox Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $53K | Sell |
72
-3
| -4% | -$2.21K | 0.01% | 241 |
|
|
2021
Q4 | $47K | Buy |
75
+73
| +3,650% | +$45.7K | 0.01% | 267 |
|
|
2021
Q3 | $1K | Buy |
2
+1
| +100% | +$500 | ﹤0.01% | 689 |
|
|
2021
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 678 |
|
|
2021
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 744 |
|
|
2019
Q4 | – | Sell |
-14
| Closed | -$4K | – | 800 |
|
|
2019
Q3 | $4K | Sell |
14
-24
| -63% | -$6.86K | ﹤0.01% | 425 |
|
|
2019
Q2 | $12K | Sell |
38
-21
| -36% | -$6.63K | ﹤0.01% | 268 |
|
|
2019
Q1 | $24K | Sell |
59
-4
| -6% | -$1.63K | ﹤0.01% | 186 |
|
|
2018
Q4 | $24K | Hold |
63
| – | – | 0.01% | 182 |
|
|
2018
Q3 | $25K | Sell |
63
-19
| -23% | -$7.54K | 0.01% | 190 |
|
|
2018
Q2 | $28K | Buy |
82
+12
| +17% | +$4.1K | 0.01% | 209 |
|
|
2018
Q1 | $24K | Buy |
70
+52
| +289% | +$17.8K | 0.01% | 248 |
|
|
2017
Q4 | $7K | Buy |
+18
| New | +$7K | ﹤0.01% | 194 |
|
|
2016
Q1 | – | Sell |
-7
| Closed | -$4K | – | 383 |
|
|
2015
Q4 | $4K | Buy |
+7
| New | +$4K | ﹤0.01% | 262 |
|